4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001962926-26-000008
CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (option exercise)
- CHIEF SCIENTIFIC OFFICER acquired 11,817 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Option exercise 10b5-1 | +11,817 | $0.34 | $4,018 | 240,777 | D |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Conversion 10b5-1 | −11,817 | 228,960 | D | ||
| Derivatives | |||||||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Option exercise · Share Option (right to buy) 10b5-1 | −11,817 | 142,898 | D | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Conversion · American Depositary Shares 10b5-1 | +3,939 | 3,939 | D | ||
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Sale · American Depositary Shares 10b5-1 | −3,020 | $53.13 | $160,462 | 919 | D |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Sale · American Depositary Shares 10b5-1 | −519 | $54.20 | $28,128 | 400 | D |
| Lin Xichen CHIEF SCIENTIFIC OFFICER | 2026-08-18 | Sale · American Depositary Shares 10b5-1 | −400 | $55.05 | $22,020 | 0 | D |
Loading xslF345X06/form4-08202026_120854.xml…